Aug 23 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO
* On August 23 entered into an amendment to its third amended and restated credit and guaranty agreement, dated as of February 13, 2012
* Amendment reduces minimum interest coverage maintenance covenant to 2.00 to 1.00 for quarters ending on or after Sept. 30, 2016
* Amendment permits issuance of secured notes with shorter maturities and incurrence of other indebtedness, in each case to repay term loans under credit agreement
* Amendment no. 13 also increases each of applicable interest rate margins under credit agreement by 0.50 percent Source: Further company coverage: VRX.TO